Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-12

FDA Approved: CETRORELIX — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Teva's original ANDA for cetrorelix acetate, a GnRH antagonist. It provides a generic option to prevent premature ovulation during controlled ovari…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetrorelix acetate (Cetrorelix acetate)

Snippet

ORIG AP for CETRORELIX (CETRORELIX ACETATE)